rs3829966

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001291549.3(CDKN1A):​c.-141-522C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0794 in 152,096 control chromosomes in the GnomAD database, including 656 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.079 ( 656 hom., cov: 32)

Consequence

CDKN1A
NM_001291549.3 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -3.21

Publications

3 publications found
Variant links:
Genes affected
CDKN1A (HGNC:1784): (cyclin dependent kinase inhibitor 1A) This gene encodes a potent cyclin-dependent kinase inhibitor. The encoded protein binds to and inhibits the activity of cyclin-cyclin-dependent kinase2 or -cyclin-dependent kinase4 complexes, and thus functions as a regulator of cell cycle progression at G1. The expression of this gene is tightly controlled by the tumor suppressor protein p53, through which this protein mediates the p53-dependent cell cycle G1 phase arrest in response to a variety of stress stimuli. This protein can interact with proliferating cell nuclear antigen, a DNA polymerase accessory factor, and plays a regulatory role in S phase DNA replication and DNA damage repair. This protein was reported to be specifically cleaved by CASP3-like caspases, which thus leads to a dramatic activation of cyclin-dependent kinase2, and may be instrumental in the execution of apoptosis following caspase activation. Mice that lack this gene have the ability to regenerate damaged or missing tissue. Multiple alternatively spliced variants have been found for this gene. [provided by RefSeq, Sep 2015]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.101 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CDKN1ANM_001291549.3 linkc.-141-522C>T intron_variant Intron 1 of 3 NP_001278478.1
CDKN1ANM_001374509.1 linkc.-50+604C>T intron_variant Intron 1 of 3 NP_001361438.1
CDKN1ANM_001374510.1 linkc.34+604C>T intron_variant Intron 1 of 2 NP_001361439.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CDKN1AENST00000448526.6 linkc.-38+650C>T intron_variant Intron 1 of 3 3 ENSP00000409259.3
CDKN1AENST00000615513.4 linkc.-6+650C>T intron_variant Intron 1 of 2 2 ENSP00000482768.1
CDKN1AENST00000459970.1 linkn.43+604C>T intron_variant Intron 1 of 2 5

Frequencies

GnomAD3 genomes
AF:
0.0795
AC:
12075
AN:
151978
Hom.:
656
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0169
Gnomad AMI
AF:
0.0680
Gnomad AMR
AF:
0.0846
Gnomad ASJ
AF:
0.191
Gnomad EAS
AF:
0.108
Gnomad SAS
AF:
0.0500
Gnomad FIN
AF:
0.137
Gnomad MID
AF:
0.123
Gnomad NFE
AF:
0.101
Gnomad OTH
AF:
0.0880
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.0794
AC:
12072
AN:
152096
Hom.:
656
Cov.:
32
AF XY:
0.0833
AC XY:
6194
AN XY:
74334
show subpopulations
African (AFR)
AF:
0.0169
AC:
700
AN:
41506
American (AMR)
AF:
0.0846
AC:
1292
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
0.191
AC:
664
AN:
3470
East Asian (EAS)
AF:
0.108
AC:
560
AN:
5176
South Asian (SAS)
AF:
0.0499
AC:
240
AN:
4814
European-Finnish (FIN)
AF:
0.137
AC:
1447
AN:
10558
Middle Eastern (MID)
AF:
0.119
AC:
35
AN:
294
European-Non Finnish (NFE)
AF:
0.101
AC:
6887
AN:
67978
Other (OTH)
AF:
0.0875
AC:
185
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
556
1111
1667
2222
2778
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
132
264
396
528
660
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0913
Hom.:
98
Bravo
AF:
0.0742
Asia WGS
AF:
0.0640
AC:
221
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.82
CADD
Benign
3.5
DANN
Benign
0.64
PhyloP100
-3.2

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3829966; hg19: chr6-36644951; API